First Mercantile Trust’s Acadia Pharmaceuticals ACAD Stock Holding History

First Mercantile Trust’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$77K	Sell	4,639 -317	-6%	-$6.11K	0.01%	721
2021 Q2	$121K	Buy	4,956 +2,722	+122%	+$61.4K	0.01%	626
2021 Q1	$58K	Sell	2,234 -1,035	-32%	-$45.6K	0.01%	765
2020 Q4	$175K	Sell	3,269 -371	-10%	-$18.4K	0.02%	485
2020 Q3	$182K	Sell	3,640 -1,375	-27%	-$59.4K	0.02%	445
2020 Q2	$243K	Sell	5,015 -1,754	-26%	-$84.2K	0.03%	325
2020 Q1	$286K	Buy	6,769 +5,109	+308%	+$211K	0.04%	250
2019 Q4	$71K	Buy	+1,660	New	+$72.2K	0.01%	751
2014 Q2	–	Sell	-12,730	Closed	-$310K	–	1151
2014 Q1	$310K	Buy	+12,730	New	+$322K	0.02%	717

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

First Mercantile Trust's ACAD Position: Q3 2021 in Review

First Mercantile Trust reduced its Acadia Pharmaceuticals (ACAD) stake by 6.4% in Q3 2021, selling an estimated $6.11K and leaving 4,639 shares worth $77K. The position accounts for 0.01% of the portfolio, ranked #721.

First Mercantile Trust first reported a position in ACAD in Q1 2014 and has held it in 9 quarters since. The position peaked at $310K in Q1 2014. 237 funds tracked by Wall St. Rank hold ACAD as of Q3 2021.

First Mercantile Trust held 4,639 shares of Acadia Pharmaceuticals worth $77K as of Q3 2021.
First Mercantile Trust sold 317 Acadia Pharmaceuticals shares in Q3 2021, an estimated $6.11K.
Acadia Pharmaceuticals made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #721 holding.
First Mercantile Trust first reported a position in Acadia Pharmaceuticals in Q1 2014 and has held it in 9 quarters since.
First Mercantile Trust's Acadia Pharmaceuticals position peaked at $310K in Q1 2014.
237 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.